期刊文献+

硫酸头孢喹肟在猪体内的药动学研究 被引量:4

Studies on cefquinome sulphate for injectable suspension and its pharmacokinetics in swine
下载PDF
导出
摘要 建立猪血浆中硫酸头孢喹肟的SPE—HPLC测定方法,对硫酸头孢喹肟在猪体内的药动学特征进行研究。选用健康猪6头,进行单次肌肉注射2mg·kg^-1自制的2.5%硫酸头孢喹肟注射液,提取血浆药物经SPE柱净化后进行HPLC分析。色谱条件为C18反相柱,流动相。高氯酸钠-磷酸-三乙胺缓冲液(pH3.6)与乙腈混合液(体积比为90:10)。结果显示,硫酸头孢喹肟在0.05~25μg·mL^-1线性关系良好(R^2=0.9986),最低检测限为0.05μg·mL^-1。经3p97软件分析结果显示:硫酸头孢喹肟的药时数据适合一级吸收二室模型,主要药动学参数:tmax为(0.80±0.05)h,Cmax为(2.44±0.24)μg·mL^-1,AUC为(7.28±1.11)μg·mL^-1·h,T1/2β为(2.28±0.49)h。结果提示:健康猪单次肌肉沣射硫酸头孢喹肟后吸收迅速,持效时间较长,临床用药18h后仍能维持对常见病原菌的有效血药浓度。建议临床用药:2mg·kg^-1(以头孢喹肟计),1日1次。 SPE-HPLC method was established to determine cefquinome sulphate, and to study the pharmacokinetics of cefquinome sulphate iu swine plasma. Cefquinome sulphate were administrated i. m. at a dose of 2 μg · kg^-1 to six swine. After extracted with methanol, cefquinnme sulphate concentration of preparation samples were determined by HPLC/UV with solid phase extraction method. C18 was used as the revesed column, sodium perchlorate-phosphoric acid buffer (pH 3.6) : aeetonitrile (90: 10, V/V) as the mobile phate, the eoncentration-time date were analyzed with 3p97 computer program. The results indieat that the standard eurves for cefquinome is linar in a range of 0. 05 -25 μg · mL^-1 ( R2 =0. 998 6) , the limit of detection was 0. 05 μg· mL^-1 ; the results suggest that the kinetics of the injection is fit to two compartment model with first order absorption. The main parameters of cefquinome sulphate is tmax = (0.80±0.05) h, C = (2.44±0.24) μg· mL^-1, AUC= (7.28±1.11)μg·mL^-1· h, T1/2β= (2.28± 0.49) h. We eonelud that eefquinome sulphate could be absorbed rapidly, long persistence effective time, there is enough effect after 18 h by i.m. eefquinome sulohate. 2 mg·kg^-1 and 1 day 1 time is adviced.
出处 《南京农业大学学报》 CAS CSCD 北大核心 2009年第2期102-106,共5页 Journal of Nanjing Agricultural University
基金 国家自然科学基金项目(30771626)
关键词 硫酸头孢喹肟 药动学 SPE—HPLC cefquinome sulphate pharmacokinetics SPE-HPLC swine
  • 相关文献

参考文献12

  • 1CVMP( Committee for Veterinary Medicial Products) Cefquinome Summary Report [ R] //The European Agence for the Evaluation of Medicinal Products. UK, 1995 : 5.
  • 2CVMP(Committee for Veterinary Medical Products) Cefquinome Summary Report-1 [ R] //The European Agence for the Evaluation of Medicinal Products. UK, 1998:405.
  • 3CVMP( Committee for Veterinary Medical Products) Cefquinome Summary Report-1 [ R] //The European Agence for the Evaluation of Medicinal Products. UK, 1999:545.
  • 4Limbert M, Isert D, Klesel N, et al. Antibacterial activities in vitro and in vivo and pharmacokineties of cefquinome, a new broad-spectrum cephalosporin [J]. Journal of Antimicrobial Chemotherapy, 1991, 35( 1 ) : 14 - 19.
  • 5王付民,陈杖榴.头孢喹诺的研究进展[J].动物医学进展,2004,25(4):50-53. 被引量:44
  • 6Suheren G, Knappstein K. Detection of cefquinome in milk by LC and screening methods [ J ]. Analytica Chimica Acta, 2003, 483: 363 - 372.
  • 7Verdon E, Couor P. HPLC/UV Determination of residues of cephalosporins in pork and beer muscle tissues [ C ] //4th International Symposium on Hormone and Veterinary Drug Residue Analysis in AFSSA-LERMVD. Antwerp of Belgium, 2002.
  • 8Errecalde C A, Prieto G F, Puelles I, et al. Cefquinome pharmacokinetics in calves by intramuscular administration [ J]. Rev Col Pec Vol, 2002, 15(3): 281-285.
  • 9Ehingera A M, Schmidtby H, Kietzmannc M. Tissue distribution of cefquinome after intramammary and "systemic" administration in the isolated perfused bovine udder [ J]. Journal of Veterinary Pharmacology and Therapeutics, 2005, 172( 1 ) : 147- 153.
  • 10Thomas E, Heuwieser W, Allan M J, et al. Pharmacokinetics of cefquinome in the bovine dry. udder secretions used as basis for it rinse-titration of a new intramammary cefquinome fommlation [ C ] //The 9th International Congress of the European Association of Veterinary. Pharmacology and Toxicology, Lisbon, 2003 : 282 - 307.

二级参考文献25

  • 1Allan M J,Thomas E. Pharmacokinetics of cefquinome after parenteral administration of an aqueous solution in the horse[J]. J Vet Pharmacol Therap, 2003,26 (1): 82-307.
  • 2CVMP(Committee for Veterinary Medicial Products), 1995,Cefquinome Summary Report,EMEA/MRL/005/95.
  • 3Cefquinome safety and toxicological data, Obiettivi-e-Documenti. -Veterinari. 1996,17:444-445.
  • 4CVMP (Committee for Veterinary Medicial Products), 1998, Cefquinome Summary Report-1,EMEA/MRL/405/98.
  • 5CVMP (Committee for Veterinary Medicial Products), 1999, Cefquinome Summary Report-2,EMEA/MRL/545/99.
  • 6Shpigel N Y, Schmid P. Treatment of acute mastitis with cefquinome[J]. Tierarztliche Praxis, 1997,25 (3): 200-206.
  • 7Winter P, Baumgartner W, Barillet F, et al. Sensitivity of mastitis pathogens of ewes to antimicrobial drugs [J]. Proceedings of the Sixth International Symposium on the Milking of Small Ruminants, 1999,196-198.
  • 8Pengov A. Treament of clinical and subclinical mastitis cases with Cobactan[J]. Veterinarske Novice (Slovenia), 2001,27 (4): 145-148.
  • 9Navetat H, Griers P, Lancar R, et al. The efficacy of cefquinome in the treatment of infectious enzootic pneumonia in young cattle[J]. Bulletin Des G T V,1996, (1) :21-25.
  • 10Scott P R. A field study of respiratory disease affecting housed beef calves in the UK[J]. Cattle Practice, 1995,3:393-401.

共引文献43

同被引文献20

  • 1廖延雄.胸膜肺炎(嗜血杆菌)放线杆菌[J].江西畜牧兽医杂志,1994,13(1):1-9. 被引量:13
  • 2高延玲,陈杖榴,王付民.抗微生物药物PK-PD研究在优化兽药给药方案中的应用[J].中国兽药杂志,2005,39(8):27-31. 被引量:5
  • 3邵意阳,屈一新,任慧.硫酸头孢喹肟的合成[J].中国医药工业杂志,2007,38(6):405-406. 被引量:10
  • 4SHIBAHARA T,SATO K,ISHIKAWA Y.Porcine circovirus induces B lymphocyte detection in pigs wasting disease syndrome[J].J Vet Med Sci,2000,62(11):1125-1131.
  • 5ERIC V,PIERRICK C.Multiresidue analytical method for the determination of eight penicillin antibiotics in muscle tissue by ion-Pair reverse-phase HPLC after precolumn derivatization[J].Journal of AOAC Internationa1,1999,82:1083-1095.
  • 6WILUAM A M,Determination of free metabolites of ceftiofur in animal tissues with an automated liquid chromatographic cleanup[J].Journal of AOAC International,1998,81:709-713.
  • 7Shpigel N Y, Levin D, Winkler M.Efficacy of Cefquinome forTreatment of Cows with Mastiffs Experimentally Induced Using Esch-erichia coli.Journal of Dairy Research, 1997.
  • 8Thomas E, Thomas V,Wilhelm C.Antibaeterial activity ofcefquinome against equine bacterial pathogens. Vet Microbi-ol, 2006.
  • 9Amiridis GS, ,Fthenakis GC, Dafopoulos J, et al.Use of cefquinome for prevention and treatment of bovine endometritis, loumal of Veterinary Phar macology and Therapeutics, 2003.
  • 10Rose M,Wiss/er R,Zschiesche E,et al.Efficacy and tolerance of a new cephalosporin, eefquinome, for mulation for treatment of bacterial respiratory diseases of pigs. Tierartliehe Praxis Ausgabe G Grossiere NUZTIERE, 2000.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部